A share price of Nkarta Inc [NKTX] is currently trading at $10.82, up 0.09%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The NKTX shares have gain 21.30% over the last week, with a monthly amount drifted -10.43%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 25, March 2024, Nkarta Announces Pricing of $240 Million Underwritten Offering. In a post published today on Yahoo Finance, Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced the pricing of an underwritten offering of 21,010,000 shares of its common stock at a price of $10.00 per share and pre-funded warrants to purchase 3,000,031 shares of common stock. The pre-funded warrants are being sold at a price of $9.9999 per warrant, which represents the per share offering price for the common stock less the $0.0001 per share exercise price.
From an analyst’s perspective:
Nkarta Inc [NASDAQ: NKTX] stock has seen the most recent analyst activity on March 22, 2024, when Raymond James downgraded its rating to a Outperform and also boosted its price target to $16 from $13. Previously, Oppenheimer downgraded its rating to Perform on December 22, 2022. On October 10, 2022, Canaccord Genuity initiated with a Buy rating and assigned a price target of $25 on the stock. Needham started tracking the stock assigning a Buy rating and suggested a price target of $26 on July 28, 2022. SVB Leerink initiated its recommendation with a Outperform and recommended $30 as its price target on July 18, 2022. Raymond James started tracking with a Outperform rating for this stock on March 11, 2022, and assigned it a price target of $17. In a note dated March 08, 2022, H.C. Wainwright initiated an Buy rating and provided a target price of $25 on this stock.
Nkarta Inc experienced fluctuations in its stock price throughout the past year between $1.28 and $16.24. Currently, Wall Street analysts expect the stock to reach $21.6 within the next 12 months. Nkarta Inc [NASDAQ: NKTX] shares were valued at $10.82 at the most recent close of the market. An investor can expect a potential return of 99.63% based on the average NKTX price forecast.
Analyzing the NKTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.3, Equity is -0.37 and Total Capital is -0.37. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.32.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.31 points at the first support level, and at 9.79 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.59, and for the 2nd resistance point, it is at 12.35.
Nkarta Inc [NKTX] reported earnings per share of -$0.57 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.59/share, meaning a difference of $0.02 and a surprise factor of 3.40%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.52 per share as compared to estimates of -$0.67 per share, a difference of $0.15 representing a surprise of 22.40%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Nkarta Inc [NASDAQ:NKTX] is 10.85. Also, the Quick Ratio is 10.85, while the Cash Ratio stands at 1.33.
Transactions by insiders
Recent insider trading involved RA CAPITAL MANAGEMENT, L.P., Director, that happened on Mar 27 ’24 when 3.0 million shares were purchased. Director, George Simeon completed a deal on Mar 27 ’24 to buy 2.0 million shares. Meanwhile, Chief Technical Officer Brandenberger Ralph sold 8367.0 shares on Mar 01 ’24.
